KEITH COKER: Open Payments
NPI 1376511451 · WAUCHULA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$321 in 15 payments from 7 companies in 2025. Trend: 2023 $580 · 2024 $578 · 2025 $321
Food & beverage: $321
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $143 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $43 |
| Merck Sharp & Dohme LLC | 1 | $33 |
| Lilly USA, LLC | 2 | $32 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $30 |
| Abbott Laboratories | 1 | $24 |
| GlaxoSmithKline, LLC. | 1 | $16 |
Products named: FARXIGA, JARDIANCE, AIRSUPRA, VERQUVO, VPRIV, FREESTYLE LIBRE 3, MOUNJARO, ZEPBOUND.
Industry payments across FL — which companies pay providers there.
